Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF)
Author(s) -
А. Тазуми,
Yasunori Maeda,
Colin E. Goldsmith,
Wilson A. Coulter,
Charlene Mason,
B.C. Millar,
Mark McCalmont,
Jackie Rendall,
J.S. Elborn,
Motoo Matsuda,
John E. Moore
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp213
Subject(s) - azithromycin , cystic fibrosis , microbiology and biotechnology , streptococcus pneumoniae , group a , group b , macrolide antibiotics , streptococcus , medicine , immunology , biology , erythromycin , antibiotics , bacteria , genetics
Although long-term use of azithromycin has shown a significant clinical improvement for patients with cystic fibrosis (CF), its long-term effect on the susceptibility of commensal flora within CF airways has not yet been examined. We therefore suggest that long-term use of azithromycin increases macrolide resistance in commensal streptococci.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom